News

Published on 15 Jan 2024 on Zacks via Yahoo Finance

Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why


Article preview image

While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn't easy.

Often, the direction of a stock's price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it's important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going.

Investors looking to make a profit from stocks that are currently on the move may find our "Recent Price Strength" screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.

NASDAQ.SYRS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Syros Pharmaceuticals Inc (SYRS) Q3 2024 Earnings Call Highlights: Strategic...

Revenue: No revenue recognized in Q3 2024, compared to $3.8 million in Q3 2023. R&D Expenses: $20...

GuruFocus.com · via Yahoo Finance 1 Nov 2024

Syros Pharmaceuticals Inc (SYRS) Q2 2024 Earnings Call Highlights: Strategic...

Revenue: No revenue recognized in Q2 2024, compared to $2.8 million in Q2 2023. R&D Expenses: $22...

GuruFocus.com · via Yahoo Finance 9 Oct 2024

Insider Buying: President & CEO Conley Chee Acquires Shares of Syros...

On the date of the purchase, shares of Syros Pharmaceuticals Inc were priced at $1.61, leading to...

GuruFocus.com · via Yahoo Finance 22 Sep 2024

Insider Buying: CFO Jason Haas Acquires 100,000 Shares of Syros Pharmaceuticals...

Syros Pharmaceuticals Inc (NASDAQ:SYRS) is a biopharmaceutical company focused on the development...

GuruFocus.com · via Yahoo Finance 22 Sep 2024

Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) high institutional ownership speaks...

Key Insights Significantly high institutional ownership implies Syros Pharmaceuticals' stock pric...

Simply Wall St. · via Yahoo Finance 21 Jun 2024

Analysts Estimate Syros Pharmaceuticals, Inc. (SYRS) to Report a Decline in Earnings: What to Look...

The market expects Syros Pharmaceuticals, Inc. (SYRS) to deliver a year-over-year decline in earn...

Zacks via Yahoo Finance 1 May 2024

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2023 Earnings Call Transcript March 27, 2024 Syros P...

Insider Monkey via Yahoo Finance 29 Mar 2024

Syros (SYRS) Stock Surges 200% in 3 Months: Here's Why

Syros Pharmaceuticals, Inc. SYRS shares have skyrocketed 200% in the past three months compared w...

Zacks via Yahoo Finance 22 Jan 2024

Syros Pharmaceuticals, Inc. (SYRS) Is a Great Choice for 'Trend' Investors, Here's Why

While "the trend is your friend" when it comes to short-term investing or trading, timing entries...

Zacks via Yahoo Finance 15 Jan 2024

Are You Looking for a Top Momentum Pick? Why Syros Pharmaceuticals, Inc. (SYRS) is a Great Choice

Momentum investing revolves around the idea of following a stock's recent trend in either directi...

Zacks via Yahoo Finance 15 Jan 2024